250 mg 250 mg Pill: orange, capsule/oblong
The pill with imprint 250 mg 250 mg (Orange, Capsule/Oblong, 0mm) has been identified as Erythromycin Delayed Release 250 mg and is used for Bronchitis, Bowel Preparation, Bacterial Endocarditis Prevention, Bartonellosis, and Bullous Pemphigoid. It belongs to the drug class macrolides and is not a controlled substance.
Images for 250 mg 250 mg
Erythromycin Delayed Release
- Imprint
- 250 mg 250 mg
- Strength
- 250 mg
- Color
- Orange (orange transparent body and orange opaque cap)
- Shape
- Capsule/Oblong (capsule containing white enteric-coated pellets)
- Availability
- Prescription only
- Drug Class
- Macrolides
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dr. Reddy's Laboratories, Inc.
- National Drug Code (NDC)
- 75907-0076
Related images for "250 mg 250 mg"
More about erythromycin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (67)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: macrolides
- Breastfeeding
- En español
Patient resources
Other brands
Erythrocin, EryPed, Eryc, Erythrocin Lactobionate, ... +4 more
Professional resources
- Erythromycin monograph
- Erythromycin Ethylsuccinate (AHFS Monograph)
- Erythromycin Lactobionate (AHFS Monograph)
- Erythromycin Stearate (AHFS Monograph)
- Erythromycins General Statement (AHFS Monograph)
Other brands
Erythrocin, EryPed, PCE Dispertab, Ery-Tab, E.E.S. Granules
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.